| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/23/1993 | US5196404 Inhibitors of thrombin |
| 03/23/1993 | CA1314906C Didehydro vitamin d -derivatives |
| 03/23/1993 | CA1314891C Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid like activity |
| 03/20/1993 | CA2078606A1 Dihydropyridine derivatives useful in antitumor therapy |
| 03/18/1993 | WO1993005169A1 Hybrid cytokines |
| 03/18/1993 | WO1993005168A1 Dna sequences encoding gelonin polypeptide |
| 03/18/1993 | WO1993005150A1 Collagen-induced platelet aggregation inhibitor |
| 03/18/1993 | WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS |
| 03/18/1993 | WO1993005064A1 Steroid sulphatase inhibitors |
| 03/18/1993 | WO1993005063A1 Steroid sulphatase inhibitors |
| 03/18/1993 | WO1993005055A1 Novel sphingoglycolipid and use thereof |
| 03/18/1993 | WO1993005027A1 Triazolylated tertiary amine compound or salt thereof |
| 03/18/1993 | WO1993005023A1 6((2-hydroxyethyl)amino alkyl)-5,11-dioxo-5,6-dihydro-11-h-indeno(1,2-c)isoquinoline and their use as antineoplastic agents |
| 03/18/1993 | CA2305767A1 Steroid sulphatase inhibitors |
| 03/18/1993 | CA2305758A1 Steroid sulphatase inhibitors |
| 03/18/1993 | CA2305749A1 Steroid sulphatase inhibitors |
| 03/18/1993 | CA2117174A1 Collagen-induced platelet aggregation inhibitor |
| 03/18/1993 | CA2116680A1 6((2-hydroxyethyl)amino alkyl)-5,11-dioxo-5,6- dihydro-11-h-indeno(1,2-c)isoquinoline and their use as antineoplastic agents |
| 03/18/1993 | CA2116533A1 Hybrid cytokines |
| 03/17/1993 | EP0532190A2 Benzo f quinolinones as 5-alpha-reductase inhibitors |
| 03/17/1993 | EP0532156A1 Physiologically active diterpenoid |
| 03/17/1993 | EP0531472A1 Humanized and chimeric monoclonal antibodies |
| 03/17/1993 | EP0531461A1 Biologically active peptides containing d-2-alkyltryptophan. |
| 03/17/1993 | EP0531434A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 03/17/1993 | EP0531419A1 Bistriazenes as chemotherapeutic agents |
| 03/17/1993 | EP0531369A1 1,4-dihydropyridines for application in combatting resistance to drugs |
| 03/17/1993 | EP0531342A1 Cyclized and linear therapeutic peptides |
| 03/17/1993 | EP0345308B1 Ornithine derivatives and their use as inhibitors of methotrexate resistant cells |
| 03/17/1993 | CN1069981A Mono and bis alkylamino-anthracyclines |
| 03/17/1993 | CN1069974A Triazolyl-substituted tertiary amino compounds and their salts |
| 03/17/1993 | CN1020097C Process for substituted benzene derivative |
| 03/16/1993 | US5194645 Trans-pt (iv) compounds |
| 03/16/1993 | US5194644 Ethylene-substituted phenylalkylethylene-diamine-platinum (ii or iv) derivatives and phenylalkylethylenediamines |
| 03/16/1993 | US5194614 Antiischemic agents, analgesics, immunology, sedatives or hypoglycemic agents |
| 03/16/1993 | US5194611 Separation technique for a mixture of (6RS)-diastereoisomers of an ammonium salt of N5 -methyl-5,6,7,8-tetrahydrofolic acid into single (6R) and (6S)-diastereoisomers |
| 03/16/1993 | US5194594 Conjugation With Heterobifunctional Reagent, Radionucleotide Label |
| 03/16/1993 | US5194586 Adult T Cell Leukemia Associated Antigen |
| 03/16/1993 | US5194581 Biodegradable poly(phosphoesters) |
| 03/16/1993 | CA1314551C Poly-4-aminopyrrole-2-carboxamido derivatives and their use as site specific alkylating agents |
| 03/16/1993 | CA1314547C L-glutamic acid derivatives |
| 03/10/1993 | EP0531080A2 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene protein |
| 03/10/1993 | EP0531031A1 Compositions for use in cancer therapy |
| 03/10/1993 | EP0530980A1 Neristatin 1 and a composition comprising the compound for the treatment of lymphocytic leukemia |
| 03/10/1993 | EP0530937A1 Collagen-induced platelet aggregation inhibitor |
| 03/10/1993 | EP0530505A2 Hydantoin derivatives |
| 03/10/1993 | EP0364490B1 A method for detecting a retinoblastoma gene defect in tumors using a retinoblastoma gene probe |
| 03/10/1993 | CN1069731A Dibenz |b,f¨ |1,4¨ oxazepin-11(10H)-ones for multidrug resistance reversing agents |
| 03/10/1993 | CN1069722A 4-Demethoxy-4-amino daunomycinone and process for preparing same |
| 03/09/1993 | US5192746 Cyclic cell adhesion modulation compounds |
| 03/09/1993 | US5192744 Thrombospondin |
| 03/09/1993 | US5192525 High affinity tamoxifen derivatives and uses thereof |
| 03/09/1993 | CA1314283C Pyrazine diazohydroxide compounds and methods for their production and use |
| 03/09/1993 | CA1314231C Ifosphamide lyophilisate and process for its preparation |
| 03/09/1993 | CA1314214C Antineoplastic agent-entrapping liposomes |
| 03/09/1993 | CA1314213C Phospholipid delivery vehicle for aqueous-insoluble active ingredients |
| 03/09/1993 | CA1314209C Composition and method for use for liposome encapsulated compounds for neutron capture tumor therapy |
| 03/05/1993 | CA2077322A1 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| 03/04/1993 | WO1993004167A1 In vivo gene transfer using implanted retroviral producer cells |
| 03/04/1993 | WO1993004056A1 New leukotriene-b4 antagonists, methods of preparing them and their use as drugs |
| 03/04/1993 | WO1993004048A1 New pyrazine derivatives, their preparation and their use |
| 03/04/1993 | WO1993003770A1 Method and compositions for cellular reprogramming |
| 03/04/1993 | WO1993003730A1 Protein kinase c inhibition and novel compound balanol |
| 03/04/1993 | WO1993003713A1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 03/04/1993 | WO1993003668A1 Cardiac output probe assembly |
| 03/04/1993 | WO1992020650A3 Phosphite-borane compounds, and method of making and using the same |
| 03/04/1993 | WO1992018089A3 Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells |
| 03/04/1993 | CA2115994A1 Protein kinase c inhibition and novel compound balanol |
| 03/04/1993 | CA2115755A1 New pyrazine derivatives, their preparation and their use |
| 03/04/1993 | CA2115262A1 In-vivo gene transfer using implanted retroviral producer cells |
| 03/04/1993 | CA2114951A1 New leukotriene-b antagonists, methods of preparing them and their use as drugs |
| 03/03/1993 | EP0530087A1 Naphthylethylurea and naphthylethylthiourea compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/03/1993 | EP0529749A1 Leukotriene-B4-antagonists, method for their preparation, and their use as medicaments |
| 03/03/1993 | EP0529715A1 Sulfated glycosaminoglycanoid derivatives |
| 03/03/1993 | EP0529528A2 Novel vitamin D3 analogues |
| 03/03/1993 | EP0529462A1 Benzodioxan derivatives |
| 03/03/1993 | EP0529386A1 Dibenz[B,F][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents |
| 03/03/1993 | EP0529160A1 Gene protein products and methods of cell therapy |
| 03/03/1993 | EP0529023A1 Therapeutically useful peptides and peptides fragments |
| 03/03/1993 | EP0528975A1 Growth inhibitors and methods of treating cancer and cell proliferative diseases |
| 03/03/1993 | EP0528820A1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase. |
| 03/03/1993 | EP0512076A4 Method of treating cancer using structured lipids |
| 03/03/1993 | EP0419501B1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
| 03/03/1993 | EP0211013B1 Immunotherapeutic methods and compositions employing antigenes characteristic of malignant neoplasms |
| 03/02/1993 | US5191072 Lipid a monosaccharide analogues |
| 03/02/1993 | US5191067 For treatment of fibroblast growth factor mediated pathophysiological conditions |
| 03/02/1993 | US5190946 Piperazine compounds restore sensitivity to drug resistant cancer cells |
| 03/02/1993 | US5190935 Vitamin d analogues |
| 03/02/1993 | US5190741 Aminopropyl Radioactive Iodobenzamides |
| 03/02/1993 | CA1314049C 3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine |
| 03/02/1993 | CA1314042C Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents |
| 03/01/1993 | WO1993004689A1 Antineoplastic drug of plant extraction and process for the preparation thereof |
| 02/24/1993 | EP0528767A1 Antibody derivatives |
| 02/24/1993 | EP0528615A1 Cribrostatins 1 and 2 |
| 02/24/1993 | EP0528583A1 Isolation and structure of the cell growth inhibitory cycloheptapeptide axinastatin 1 |
| 02/24/1993 | EP0528527A2 Conjugates |
| 02/24/1993 | EP0528486A2 Non-substrate inhibitors of farnesyl protein transferase |
| 02/24/1993 | EP0528369A2 Cyclic imino derivatives, pharmaceutical compositions containing them and process for their preparation |
| 02/24/1993 | EP0528312A2 Cyclic peptides and use thereof |
| 02/24/1993 | EP0527804A1 Gene therapy for cell proliferative diseases |
| 02/24/1993 | EP0527802A1 Ligand for the neu gene product. |